Involves the taking of medicine for the purpose of preventing or reducing organ rejection in patients receiving organ transplants.
Involves the taking of medicine for the purpose of preventing or reducing organ rejection in patients receiving organ transplants.
Name | Drug Class | Updated |
---|---|---|
Basiliximab | Interleukin inhibitors | 16-Aug-2023 |
Sirolimus (systemic) (monograph) | Drugs | 15-Aug-2023 |
Sirolimus | MTOR inhibitors | 15-Aug-2023 |
Tacrolimus (oral and injection) | Calcineurin inhibitors | 12-Aug-2023 |
Tacrolimus (systemic) (monograph) | Drugs | 12-Aug-2023 |
Everolimus | MTOR inhibitors | 11-Aug-2023 |
Simulect | Interleukin inhibitors | 05-Aug-2023 |
Prograf | Calcineurin inhibitors | 05-Aug-2023 |
Cellcept | Selective immunosuppressants | 05-Aug-2023 |
Zortress | MTOR inhibitors | 14-Jul-2023 |
Rapamune | MTOR inhibitors | 11-Jul-2023 |